Former FDA Commissioner Scott Gottlieb Opposes RFK Jr.'s Nomination to Lead HHS

Nov 29, 2024, 06:28 PM

Robert F. Kennedy Jr.'s potential nomination to lead the Department of Health and Human Services (HHS) under President-elect Donald Trump is facing opposition from former FDA Commissioner Scott Gottlieb, who now serves on Pfizer's board. Gottlieb has expressed 'deep concerns' about Kennedy's intentions to roll back core public health protections, particularly regarding childhood vaccines. He warned that if Kennedy follows through with his plans, it could result in outbreaks of diseases like measles, mumps, rubella, and even polio. Vaccine researcher Peter Hotez has also shared his thoughts on Kennedy and other Trump health nominees. Gottlieb's opposition is part of a broader tension between Trump's health nominees and the pharmaceutical industry, with potential regulatory battles looming. Kennedy's nomination, if confirmed, could lead to significant changes in health policy, potentially at odds with the rest of the Trump administration's agenda.